Skip to main content
. 2022 Jan 31;15(2):176. doi: 10.3390/ph15020176
AE adverse event
AHCC®® active hexose correlated compound
FFLZ fucose-containing fraction of G. lucidum
HCC hepatocellular carcinoma
HP hematologic parameters
IC50 half-maximal inhibitory concentration
LOA loss of appetite
MDS myelodys plastic syndromes
MM medicinal mushrooms
OS overall survival
QOL quality of life
RCT randomized, placebo-controlled, double-blind clinical trial
ROS reactive oxygen species
SDL superfine dispersed lentinan
SPG polysaccharide schizophyllan